Elective Submandibular Gland Resection in Patients with Squamous Cell Carcinomas of the Tongue

Document Type : Original

Authors

1 Otolaryngology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

2 Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Abstract

Introduction:
Submandibular gland resection is a controversial issue in patients with oral tongue squamous cell carcinomas (SCC). This study aimed to determine the frequency of submandibular gland involvement in patients who had undergone elective submandibular gland resection following oral tongue SCC.
 
Materials and Methods:
This cross-sectional retrospective study was performed between 2001 and 2017 on patients with oral tongue SCC who had undergone glossectomy in a referral center for otorhinolaryngology surgery, Shiraz, Iran.
 
Results:
In this study, 131 patients were included. Their mean age was 59.84 years (range: 19-86). The mean tumor size was 2.83 cm (range 0.3-7). The vast majority (92%) of the patients were at stage III-IVa and had well (55%) to moderate (31%) differentiated tumor. The mean diameter of the submandibular gland was 3.87 cm (range: 1.5-6 cm). There was only one (0.76%) patient with submandibular involvement. She was an 80-year-old woman with a T2 well differentiated tumor without cervical lymph node involvement in the neck node dissection.
 
Conclusion:
In patients with oral tongue SCC, submandibular gland involvement is rare and its elective resection in not recommended.

Keywords

References

  1. Pugazhendi SK, Thambiah L, Venkatasetty A, Thangaswamy V. Elective neck dissection versus "wait and watch" policy in tongue carcinoma. Journal of pharmacy & bioallied sciences. 2012;4(Suppl 2):S226-S9.
  2. Yang S, Wang X, Su JZ, Yu GY. Rate of Submandibular Gland Involvement in Oral Squamous Cell Carcinoma. J Oral Maxillofac Surg. 2019; 77(5):1000-8.
  3. Dundar Y, Mandle Q, Raza SN, Lin HS, Cramer J, Hotaling JM. Submandibular Gland Invasion by Oral Cavity Cancers: A Systematic Review. Otolaryngol Head Neck Surg. 2019: 194599819838475.
  4. Varra V, Ross RB, Juloori A, Campbell S, Tom MC, Joshi NP, et al. Selectively sparing the submandibular gland when level Ib lymph nodes are included in the radiation target volume: An initial safety analysis of a novel planning objective. Oral Oncol. 2019;89:79-83.
  5. Yamauchi K, Fujioka Y, Kohno N. Sentinel node navigation surgery versus observation as a management strategy for early tongue carcinoma. Head Neck. 2012;34(4):568-72.
  6. Subramaniam N, Balasubramanian D, Reddy R, Rathod P, Murthy S, Vidhyadharan S, et al. Determinants of level Ib involvement in oral squamous cell carcinoma and implications for submandibular gland-sparing neck dissection. Int J Oral Maxillofac Surg. 2018; 47(12):1507-10.
  7. Burghartz M, Hackenberg S, Sittel C, Hagen R. Surgery of the major salivary glands and its impact on salivary flow-A review. Laryngoscope. 2018.
  8. Basaran B, Ulusan M, Orhan KS, Gunes S, Suoglu Y. Is it necessary to remove submandibular glands in squamous cell carcinomas of the oral cavity? Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale. 2013;33(2):88-92.
  9. Agarwal G, Nagpure PS, Chavan SS. Questionable Necessity for Removing Submandibular Gland in Neck Dissection in Squamous Cell Carcinoma of Oral Cavity. Indian J Otolaryngol Head Neck Surg. 2016;68(3):314-6.
  10.                 Markey JD, Morrel WG, Wang SJ, Ryan WR. The effect of submandibular gland preservation during level 1B neck dissection on postoperative xerostomia. Auris Nasus Larynx. 2018;45(1):123-7.
  11. Hawkins PG, Lee JY, Mao Y, Li P, Green M, Worden FP, et al. Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life. Radiother Oncol. 2018;126(1):68-74.
  12.                 Mendenhall WM, Mendenhall CM, Mendenhall NP. Submandibular gland-sparing intensity-modulated radiotherapy. Am J Clin Oncol. 2014;37(5):514-6.
  13. Taghavi N, Yazdi I. Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts. Arch Iran Med. 2015;18(5):314-9.
  14.                 Vered M, Dayan D, Dobriyan A, Yahalom R, Shalmon B, Barshack I, et al. Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age. J Cancer Res Clin Oncol. 2010; 136(7):1039-48.
  15. Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2006; 42(3): 229-39.
  16.  Malgonde MS, Kumar M. Practicability of submandibular gland in squamous cell carcinomas of oral cavity. Indian journal of otolaryngology and head and neck surgery: official publication of the Association of Otolaryngologists of India. 2015;67(Suppl 1):138-40.
  17.  Panda NK, Patro SK, Bakshi J, Verma RK, Das A, Chatterjee D. Metastasis to submandibular glands in oral cavity cancers: Can we preserve the gland safely? Auris Nasus Larynx. 2015;42(4):322-5.
  18.  Malik A, Joshi P, Mishra A, Garg A, Mair M, Chakrabarti S, et al. Prospective study of the pattern of lymphatic metastasis in relation to the submandibular gland in patients with carcinoma of the oral cavity. Head Neck. 2016; 38(11): 1703-7.
  19.                 Cakir Cetin A, Dogan E, Ozay H, Kumus O, Erdag TK, Karabay N, et al. Submandibular gland invasion and feasibility of gland-sparing neck dissection in oral cavity carcinoma. J Laryngol Otol. 2018;132(5):446-51.

 

 

 

Iranian Journal of Otorhinolaryngology
Volume 33, Issue 1
January and February 2021
Pages 23-29

Files

Share

How to cite

Statistics